Skip to main content

2024 Program

hands shaking

Loading

Vicero

October 15, 2024
Hunt Room
Oncology
Vicero
Developing the next generation of antibody therapies, Vicero uses our proprietary VINCOBODY technology to build bi- and multi-specific antibodies and antibody drug conjugates with differentiated size, flexibility, and affinity against proven therapeutic targets. Our first focus is immuno-oncology (IO), where our lead program has the potential to address significant remaining unmet need in the IO Solid Tumor Market by maximizing efficacy while limiting immune-related toxicity. We have a plug and play pipeline for additional assets against validated oncology and immunology targets. We have a highly accomplished team with deep drug development experience and proven success bringing blockbuster drugs to the market.
Speakers
Vikram Kansra - PhD, Founder & CEO - Vicero

DOUBLE HELIX SPONSOR

HELIX SPONSOR

PREMIER SPONSOR

CONFERENCE SPONSORS